Vekade Pharma Limited in Watford, WD24 7ND

Description

Data updated on: 01-11-2023

This particular Vekade Pharma Limited business has been in this business for fourteen years, having started in 2010. Registered with number 07179980, Vekade Pharma is a Private Limited Company with office in The Wenta Business Centre Unit 15, The Wenta Business Centre, Watford WD24 7ND. The business name of the company was replaced in 2018 to Vekade Pharma Limited. This company former registered name was Himalaya Consultancy. This company's declared SIC number is 74909 which means Other professional, scientific and technical activities not elsewhere classified. Vekade Pharma Ltd filed its latest accounts for the financial period up to Fri, 31st Mar 2023. The most recent confirmation statement was submitted on Sun, 5th Mar 2023.

When it comes to the following business, just about all of director's tasks have so far been carried out by Kanjikumar M. who was appointed in 2010. Since 2012 Deepti D., had been supervising the following business until the resignation five years ago.

Previous company's names
Vekade Pharma Limited 2018-07-16
Himalaya Consultancy Limited 2010-03-05

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-03-31	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	190	185	944	1 280	100	211	1 241

Balance Sheet
Cash Bank On Hand									1 920	4 960	12 277	47 155	16 239
Current Assets	1 936	4 490	4 953	14 458	18 644	19 647	14 268	7 344	2 934	98 193	159 538	312 299	227 345
Debtors	1 018	1 068	1 595	5 083	930	6 560			1 014	83 883	129 926	138 469	170 722
Net Assets Liabilities							1 241	2 263	-6 086	5 125	8 333	12 385	20 898
Other Debtors									1 014	10 000
Total Inventories										9 350	17 335	126 675	40 384
Cash Bank In Hand	918	3 422	3 358	9 375	17 714	13 087
Net Assets Liabilities Including Pension Asset Liability	190	185	944	1 280	100	211	1 241
Tangible Fixed Assets	251	201	161	129	103	82

Capital & Reserves
Called Up Share Capital	100	100	100	100	100	100
Profit Loss Account Reserve	90	85	844	1 180		111
Shareholder Funds	190	185	944	1 280	100	211	1 241

Other Financial Data
Average Number Employees During Period									4	1	1	1	2
Creditors							13 093	5 134	9 110	93 068	151 205	299 914	206 447
Fixed Assets	251	201	161	129	103	82	66	53
Net Current Assets Liabilities	-8	24	815	1 177	18	129	1 175	2 210	-6 086	5 125	8 333	12 385	20 898
Other Creditors									4 518	1 117	55 217	55 417	45 702
Other Taxation Social Security Payable									4 592	20 112	10 315	42 364	125 355
Total Assets Less Current Liabilities	243	225	976	1 306	121	211	1 241	2 263	-6 086
Trade Creditors Trade Payables										71 839	85 673	202 133	35 390
Trade Debtors Trade Receivables										73 883	129 926	138 469	170 722
Creditors Due Within One Year Total Current Liabilities	1 944	4 466
Provisions For Liabilities Charges	53	40	32	26	21
Tangible Fixed Assets Cost Or Valuation	314	314	314	314	314	314
Tangible Fixed Assets Depreciation	63	113	153	185	211	232
Tangible Fixed Assets Depreciation Charge For Period		50
Creditors Due Within One Year		4 466	4 138	13 281	18 626	19 518	13 093
Number Shares Allotted			100	100	100	100
Par Value Share			1	1	1	1
Share Capital Allotted Called Up Paid		100	100	100	100	100
Tangible Fixed Assets Depreciation Charged In Period			40	32	26	21

Company staff

Kanjikumar M.

Role: Director

Appointed: 05 March 2010

Latest update: 23 March 2024

People with significant control

Kanjikumar M. is the individual who has control over this firm, owns over 3/4 of company shares.

Kanjikumar M.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 December 2024
Account last made up date	31 March 2023
Confirmation statement next due date	19 March 2024
Confirmation statement last made up date	05 March 2023

Annual Accounts 26 October 2013
Start Date For Period Covered By Report	2012-04-01
End Date For Period Covered By Report	2013-03-31
Date Approval Accounts	26 October 2013
Annual Accounts
Start Date For Period Covered By Report	2013-04-01
Annual Accounts
Start Date For Period Covered By Report	2014-04-01
Annual Accounts 20 September 2016
Start Date For Period Covered By Report	2015-04-01
End Date For Period Covered By Report	2016-03-31
Date Approval Accounts	20 September 2016
Annual Accounts 12 October 2017
Start Date For Period Covered By Report	2016-04-01
Date Approval Accounts	12 October 2017
Annual Accounts
Start Date For Period Covered By Report	01 April 2017
End Date For Period Covered By Report	31 March 2018
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts
Start Date For Period Covered By Report	01 April 2018
End Date For Period Covered By Report	31 March 2019
Annual Accounts 27 August 2014
End Date For Period Covered By Report	2014-03-31
Date Approval Accounts	27 August 2014
Annual Accounts 14 December 2015
End Date For Period Covered By Report	2015-03-31
Date Approval Accounts	14 December 2015
Annual Accounts
End Date For Period Covered By Report	2017-03-31
Annual Accounts
End Date For Period Covered By Report	31 March 2019

Vekade Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Kanjikumar M.

Deepti D.

People with significant control

Kanjikumar M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode